Published in
Wiley, Liver International, 12(41), p. 2885-2891, 2021
DOI: 10.1111/liv.15032
Links
Tools
Hepatocellular carcinoma risk in hepatitis C stage‐3 fibrosis after sustained virological response with direct‐acting antivirals
Journal article published in 2021 by
María Sánchez‐Azofra 
,
Inmaculada Fernández,
María L. García‐Buey,
Lourdes Domínguez‐Domínguez ,
Conrado M. Fernández‐Rodríguez ,
Antonio Mancebo,
Lucía Bonet,
Pablo Ryan,
Francisco Gea,
Antonio Díaz‐Sánchez,
Marian García‐Mayor,
Luz Martín‐Carbonero,
Pilar Castillo,
María L. Manzano,
Leticia González‐Moreno
and other authors.
,
Inmaculada Fernández,
María L. García‐Buey,
Lourdes Domínguez‐Domínguez ,
Conrado M. Fernández‐Rodríguez ,
Antonio Mancebo,
Lucía Bonet,
Pablo Ryan,
Francisco Gea,
Antonio Díaz‐Sánchez,
Marian García‐Mayor,
Luz Martín‐Carbonero,
Pilar Castillo,
María L. Manzano,
Leticia González‐Moreno
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 